Stereotaxis Reports 2026 First Quarter Financial Results
Stereotaxis, Inc. reported its first quarter financial results for 2026, showing a revenue of $6.3 million, a decrease from $7.5 million in the previous year. The company has achieved significant regulatory approvals and is executing strategic acquisitions. They anticipate double-digit revenue growth for the full year 2026, projecting annual revenue to surpass $40 million, with expectations of sequential revenue growth driven by increased manufacturing of their new products.
ST. LOUIS, May 12, 2026 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business updates and financial results for the first quarter ended March 31, 2026.